Can liver cirrhosis cause pleural effusion without worsening ascites in a patient?

Can Liver Cirrhosis Cause Pleural Effusion Without Worsening Ascites?

Yes, liver cirrhosis can definitively cause pleural effusion (hepatic hydrothorax) without clinically apparent ascites—this occurs in approximately 9% of patients with hepatic hydrothorax. 1

Pathophysiology of Hepatic Hydrothorax Without Ascites

The mechanism involves direct movement of peritoneal fluid through small diaphragmatic defects into the pleural space, driven by negative intrathoracic pressure during inspiration. 1 In some patients, this fluid transfer occurs so efficiently that ascites never accumulates to clinically detectable levels in the abdomen—the fluid moves into the chest before it can manifest as abdominal distension. 2, 3

• Right-sided predominance: Approximately 73% of hepatic hydrothorax cases occur on the right side, 17% on the left, and 10% bilaterally. 1
• The continuous pressure gradient between positive intra-abdominal pressure and negative intrathoracic pressure facilitates rapid, ongoing fluid movement through diaphragmatic defects. 4
• Larger or multiple diaphragmatic defects allow faster fluid passage, preventing ascites accumulation while causing significant pleural effusion. 4

Diagnostic Confirmation

Calculate the serum-to-pleural fluid albumin gradient: A gradient >1.1 g/dL confirms portal hypertension as the cause (hepatic hydrothorax), even without visible ascites. 1, 2

Key diagnostic steps:

• Perform diagnostic thoracentesis with cell count, differential, total protein, albumin, and culture. 1, 2
• Rule out cardiac causes (check for bilateral effusions, cardiomegaly on chest X-ray, echocardiography). 2
• Rule out malignancy (gradient ≤1.1 g/dL, left-sided effusion, or cytology positive). 2
• Exclude infection: Check pleural fluid absolute neutrophil count (>250/mm³ indicates spontaneous bacterial empyema). 2

Critical pitfall: The pleural fluid in hepatic hydrothorax may have higher protein content than concurrent ascites due to hydrostatic pressure gradients, potentially causing confusion with exudative processes. 1

Prognostic Implications

This presentation carries an extremely poor prognosis—74% mortality at 90 days despite mean MELD scores of only 14 (which would otherwise predict 6-8% mortality). 1, 2 The mortality risk exceeds that predicted by MELD score alone, warranting additional priority for liver transplantation. 1

Management Algorithm

First-line therapy:

• Dietary sodium restriction (≤88 mmol/day or 5 g salt/day). 1
• Diuretics (spironolactone with or without furosemide). 1
• Therapeutic thoracentesis as needed for dyspnea (provides only temporary relief as fluid reaccumulates rapidly). 1, 5

Second-line therapy for refractory cases:

• TIPS placement in carefully selected patients (achieves complete response in approximately 56% of cases). 1, 5, 4
• Avoid chest tube insertion due to high complication rates. 1
• Indwelling tunneled pleural catheters may be considered only in highly selected patients not candidates for TIPS, though this risks protein depletion and malnutrition. 1

Definitive therapy:

• Liver transplantation is the best option and should be pursued in all eligible patients. 1, 5
• Patients with hepatic hydrothorax meeting defined criteria receive additional MELD exception points for transplant listing. 1

Avoid: Chemical pleurodesis often leads to loculated collections and is not recommended as standard therapy. 1